|
|
|
Pharmaceutical Manufacturing and Packing Sourcer |
|
|
|
|
|
 |
| |
|
|
|
|
Industry Insight
PMPS Industry Advisor Robert Harris discusses the use of smart devices in healthcare today and how the Internet of Things can improve patient adherence and welfare. He picks out a number of articles from this edition that address the steps that pharma is taking in this field.
|
|
|
|
High Potency Drugs
Potent Protection
Knowing how to control and contain potent compounds is imperative, especially as they can be found in over a quarter of drugs around the world. With this number expected to grow, Dr Shabbir Mostafa at Aesica puts forward some of the best methods for handling these materials.
|
|
|
Potent Compounds
Safety First
John Michnick at Cambrex contemplates contract manufacturers and their conduct of projects comprising highly potent compounds. As demand for these products grows, it is crucial that those working with them are kept safe and experience, he says, is key.
|
|
|
Micronisation
Thinking Small
Elanor Pinto-Cocozza at Catalent Pharma Solutions discusses a problem that needs to be addressed: the number of drugs that are poorly soluble and permeable in the market. She argues that the answer could be micronisation, with benefits ranging from manufacturing right through to patient compliance.
|
|
|
Machines and Tooling
Time is Pressing
Natoli Engineering Company’s Robert Sedlock scrutinises the powder die filling process, and how it is hindering the creation of good quality tablets. By analysing each component in the procedure, he reveals ways to overcome the challenges associated with it.
|
|
|
|
|
Strategic Partnerships
The Extra Mile
Kamaljit Hunjam at CEVA Logistics reviews the relationship between a pharma company and its logistics provider. As one of the key links in the supply chain, this affiliation should grow and develop to serve both parties in old and new markets.
|
|
|
Temperature Control
To What Degree?
With many manufacturers now moving towards more structurally complex biotechnological drugs, it is vital to keep these drugs at the correct temperature during storage and transit. Zuellig Pharma’s Darren Wedding believes it is possible to achieve this and keep costs to a minimum.
|
|
|
Transporting Pharmaceuticals
It’s All in the Air
What is the best way to manage the temperature of your pharmaceuticals during transit? Mark Edwards at Modalis provides an overview of the different approaches currently available – including blankets and airline cargo services – which promise to optimise both cost-effectiveness and compliance.
|
|
|
Phase Change Materials
Keeping Cool
With regulators clamping down on temperature excursions, cold chain logistics is becoming more expensive. One way of bringing the cost down is the utilisation of phase change materials, suggest Jamie Chasteen at Cold Chain Technologies and Richard Harrop at Topa Thermal.
|
|
|
Clinical Trial Logistics
The Heat is On
Bringing new products to market is an increasingly expensive endeavour. As companies search for ways to cut costs while executing clinical trials, John Lee at Courier Express examines why they are looking to third-party logistics providers for a viable solution.
|
|
|
|
|
Serialisation Issues
Phasing In
To establish an efficient, compliant and cost-effective supply chain, track and trace requirements have become the norm among logistics companies. Chuck Sailer at Adents explores the importance of serialisation and discusses why managing overall equipment effectiveness is more important than ever before.
|
|
|
Electronic Packaging
A Smart Approach
The Internet of Things technology is continuously advancing – but how can the packaging sector leverage such innovation? Roosje Watson at the Centre for Process Innovation uncovers the benefits of this combination for the manufacturer, supply chain and, ultimately, the consumer.
|
|
|
Patient Adherence
Do You Remember?
New legislation, such as the EU Falsified Medicines Directive, has increased the amount of requirements in serialisation and tamper verification. Essentra’s Rupert Taylor observes the effect this can have on patient compliance, and shares advice on how to avoid the resulting financial strain.
|
|
|
|
Asset Management
Second-User Revolution
EquipNet’s Ben Potenza proposes one solution to save money on equipment: buying second-hand. As the advantages are fast becoming recognised in such a rapidly evolving marketplace, he homes in on how purchasing used assets can help with the demand for reduced costs and time to market.
|
|
|
|
|
End of the Line
Click and Collect
What are the dangers of buying pharmaceutical products on the internet? Robert Harris looks at the steps needed to prohibit counterfeit medicines from being bought online.
|
|
|
|
Comparator Drugs
Source and Supply
As clinical trials become more expensive – averaging around $36,500 per patient – Durbin’s Robert Donnell looks at the different ways to obtain comparator drugs. Covering both acquisition directly from the manufacturer and sourcing from the open market, he ponders the good and the bad points of each method.
|
|
|
|
Patient Centricity
At the Centre
As a result of headlines highlighting drug pricing in the market, patient centricity is the current buzzword of the pharma industry. Justin Schroeder at PCI Pharma Services explores why patients, rather than the product, should be the focus. |
|
|
|
|
|
 |
|
|
 |
News and Press Releases |
 |
c-LEcta signs Europe sales and distribution agreement with VWR for c-LEcta’s DENARASE®
• DENARASE® is now available through VWR’s sales channels in Europe
• VWR, part of Avantor, is a leading global provider of product and service solutions to laboratory and production customers
• Cooperation harbors the potential for c-LEcta’s product to gain additional share in a highly dynamic market
More info >> |
|
 |
White Papers |
 |
|
Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery
Presspart Manufacturing Ltd
Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >> |
|
 |
Industry Events |
 |
4th Annual Genome Editing Congress
8-9 November 2018, London, UK
Oxford Global is proud to present its 4thAnnual Genome Editing Congress taking place on 8-9 November 2018 in London. As
part of our Genomics and Synthetic Biology UK series, our congress will
bring together Over 600 delegates representing internationally renowned
research & academic institutions, clinical research institutions and
pharmaceutical companies.
More info >> |
|
|
